Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Melbourne researchers have made breakthrough discoveries that may help those suffering from skin conditions such as psoriasis. They found new molecules that control disease-causing immune cells in the skin and can be targeted without impacting the barrier that fights off cancer. To discuss, Rebecca Maddern spoke with Dr Susan...

14,052 Aufrufe • vor 2 Jahren •via X (Twitter)

1 Kommentare

Profilbild von michael richards
michael richardsvor 2 Jahren

They are trying to give a drug to me atm that will relieve my eczema but it has alot of side effects so I haven’t been injected yet still thinking about it and one is conjunctivitis I’m a chef so I said no can’t cook with that

Ähnliche Videos

"A Vasectomy Causes Chronic Health Conditions...The Research Your Doctor Keeps Hidden In This $22 Billion Dollar Industry." Dr Nicole Rivera 20% Increased Risk Of Prostate Cancer. 40% Increase In Alzheimer's Disease & Dementia. 70% Develop Autoimmune & 33% Have Chronic Pain. Urologists are unwilling to be upfront about the long term health risks of getting a vasectomy - it’s a $22 billion dollar profit driven industry. Urologists in the US were surveyed & 90% reported that they would not stop performing vasectomies, despite the evidence that undergoing a vasectomy is linked to prostate cancer & many other medical conditions. Research shows as high as 33% of men suffer from long term daily chronic testicular & groin pain because the natural duct for sperm is severed & closed off. Certain organs, including the testes, exist in what is 'a gated community' of sorts, in the body. Tiny tubes within the testes are protected by Sertoli Cells, that provide a physical barrier. The tight connections between these cells prevent blood-borne infections & poisonous molecules from entering the semen. Vasectomy & Autoimmune Disease: After a vasectomy, that protective barrier is broken & semen mixes into the bloodstream. The immune system recognizes the sperm as invading foreign agents & produces anti-sperm antibodies in 70% of men, leading to an eventual development of an Autoimmune Disease. According to a Finland study, the “presence of sperm antibodies correlates with nearly every pathological condition of the male reproductive tract.” A man’s body has a strong layer of tissue known as the Blood-Testis Barrier (BTB). Vasectomy eliminates this barrier. A man’s immune system sees the sperm as an infection that needs to be addressed, resulting in a never ending immune response, making antisperm antibodies to attack his own cells. FTD Frontotemporal Dementia & PPA Primary Progressive Aphasia Post Vasectomy: PPA & FTD are dementia syndromes that studies have shown to be 40% higher in men who have had a vasectomy. Mechanisms mediating risk include vasectomy-induced immune responses to sperm, which shares antigenic epitopes with the brain. In A 38 Year Nationwide Prostate Cancer Study: Vasectomy has a statistically significant increased long-term risk of prostate cancer occurring at a rate of 20%. Vasectomy Adverse Health Conditions Long Term: Prostate Cancer Testicular Cancer Antibody Autoimmune Disease Cardiovascular Disease Sexual Dysfunction Chronic Pain Primary Progressive Aphasia (PPA) Frontotemporal Dementia (FTD) 👇Vasectomy Causes Primary Progressive Aphasia👇 👇Vasectomy Increases Prostate Cancer👇 👇Immunological Consequences Of Vasectomy👇 Speaker: Dr Nicole Rivera

Valerie Anne Smith

341,618 Aufrufe • vor 8 Monaten

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 Aufrufe • vor 6 Monaten

Chemotherapy kills the very cells the body uses to fight cancer. A surgeon and cancer researcher just said it out loud to a national audience, and the science backing him up is growing fast. Jefferey Jaxen opens with Dr. Patrick Soon-Shiong, who told Tucker Carlson that 99.9% of oncologists pay no attention to lymphocytes, the natural killer cells and T cells that are the immune system's actual weapon against cancer, and that chemotherapy's brief response is followed by metastasis because the treatment eliminates the body's protection. The research community is beginning to build in a different direction. Researchers at Trinity College Dublin have demonstrated that interferon gamma, a naturally occurring signaling protein that activates T cells and macrophages, can be used to train immune cells before they encounter a pathogen, thereby enhancing the killing of drug-resistant tuberculosis and MRSA staph infections in both healthy and genetically vulnerable individuals. The implications reach beyond antibiotic resistance: the same principle suggests that targeted immune training for immunosuppressed individuals could replace the current practice of blanket vaccination of entire populations to protect a few. Also reported last month, a UCLA study and subsequent meta-analysis found that honeybee venom and its primary protein, melittin, induced massive cell death in triple-negative and HER2-enriched breast cancer cell lines within 60 minutes of treatment, disrupting receptor pathways that aggressive breast cancers depend on. Melittin is globally available, cost-effective, and accessible in remote regions. None of these treatments are available off the shelf yet, but the direction of the research, working with the immune system and drawing from natural environments rather than suppressing the body's own defenses, represents a genuine paradigm shift that would have been unlikely to receive funding a decade ago.

The HighWire

12,121 Aufrufe • vor 1 Monat

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure

PharmacyinUSA

15,268 Aufrufe • vor 1 Monat

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 Aufrufe • vor 10 Monaten